Amylyx Pharmaceuticals, Inc.

Q3 2025 13F Holders

Symbol
AMLX
CUSIP
03237H101
Type
Equity
Class
COM
Num filings
180
Total reported value, excl. options
$1.52 B
Manager Report Date Value ($000) Shares Option Type